Ro vs Sequence
Last updated: May 21, 2026
Quick Answer: Ro and Sequence are both telehealth platforms that connect patients with licensed providers who can prescribe GLP-1 medications for weight loss. Ro (through its “Ro Body” program) focuses on affordable, streamlined access to compounded semaglutide at roughly $149–$199/month. Sequence, now owned by WeightWatchers, takes a higher-touch approach with branded GLP-1s like Wegovy and Ozempic, more frequent physician visits, and costs that typically run $249–$399/month for the medical program alone. The right choice depends on your budget, how much clinical support you want, and whether you prefer compounded or FDA-approved branded medication.
Key Takeaways
- Ro Body offers compounded semaglutide at approximately $149–$199/month as a cash-pay option, making it one of the more affordable GLP-1 telehealth programs available [1]
- Sequence (now WeightWatchers’ clinical backbone) emphasizes FDA-approved branded GLP-1s (Wegovy, Ozempic, Rybelsus) with higher provider involvement [2][5]
- Ro uses asynchronous messaging with providers; Sequence offers more frequent video consultations and detailed metabolic lab reviews [1]
- Sequence membership typically costs $249–$399/month for the medical program, plus separate costs for branded medication unless covered by insurance [1]
- Ro suits budget-conscious users who want simple, fast access to GLP-1 therapy; Sequence suits those who want premium, physician-intensive care
- Neither program guarantees results without lifestyle changes; both require a provider evaluation before prescribing
- If cost is your top priority, DirectMeds GLP1 Semaglutide is currently one of the most affordable compounded semaglutide options on the market
- WeightWatchers acquired Sequence (formerly Weekend Health) for an effective net purchase price of $106 million [2]
What Exactly Are Ro and Sequence? (And How Do They Differ?)
Ro and Sequence are telehealth services that prescribe GLP-1 receptor agonist medications for weight management. They are not the same type of program, and that distinction matters before you spend a dollar.
Ro is a broad virtual clinic that covers multiple health conditions, including erectile dysfunction, mental health, and primary care. Its weight loss arm, Ro Body, connects patients with licensed providers via asynchronous messaging. The focus is on simplicity and cost control, with compounded semaglutide as the primary medication offering [1].
Sequence started as an independent telehealth startup called Weekend Health. WeightWatchers acquired it for approximately $106 million to serve as the clinical engine behind its GLP-1 medication program [2]. Today, Sequence operates as the physician-intensive pathway within the WW ecosystem, integrating behavioral coaching, nutrition support, and prescription access to branded GLP-1 medications like Wegovy and Ozempic [5].
Key structural differences at a glance:
| Feature | Ro Body | Sequence (via WW) |
|---|---|---|
| Medication type | Compounded semaglutide | Branded GLP-1s (Wegovy, Ozempic, Rybelsus) |
| Provider contact | Asynchronous messaging | Video visits + messaging |
| Monthly cost (program) | ~$149–$199 | ~$249–$399 |
| Behavioral support | Basic | Integrated WW coaching |
| Insurance billing | Limited | Yes, for branded meds |
| Ownership | Independent (Ro Health) | WeightWatchers |
Sources: [1][2][5]
How Much Do Ro and Sequence Treatments Cost?
Ro Body costs approximately $149–$199 per month as an all-in cash-pay price that includes telehealth visits and compounded semaglutide medication. Sequence’s medical program runs approximately $249–$399 per month, and branded GLP-1 medications are billed separately, either through insurance or out-of-pocket [1].
Here’s what drives the price gap:
- Ro’s lower cost reflects its asynchronous care model (no live video calls required), use of compounded semaglutide (which is significantly cheaper than branded Wegovy), and streamlined onboarding
- Sequence’s higher cost reflects more frequent physician video visits, detailed metabolic lab panels, and integration with WW’s behavioral coaching platform
- Branded GLP-1s like Wegovy can cost over $1,000/month without insurance, so Sequence members who don’t have coverage face significant additional out-of-pocket costs
- Ro’s compounded semaglutide pricing makes it far more accessible for people without insurance or with high deductibles
💡 If cost is your primary concern: DirectMeds GLP1 Semaglutide is currently one of the most affordable compounded semaglutide programs available in 2026. It’s worth comparing before committing to either Ro or Sequence.
Also see our expert guide on the cheapest GLP-1 options without insurance for a broader comparison.
Who Should Use Ro vs. Who Should Use Sequence?
Choose Ro if you want affordable, fast access to GLP-1 therapy without a lot of hand-holding. Choose Sequence if you want physician-intensive support, prefer FDA-approved branded medications, and are willing to pay more or use insurance.
Ro is a better fit for you if:
- You’re budget-conscious and prefer a flat monthly rate
- You’re comfortable communicating with your provider via text/messaging rather than video
- You don’t have insurance coverage for GLP-1 medications
- You’ve already done your research and just need a prescription and medication
Sequence is a better fit for you if:
- You want regular video consultations with a physician
- You prefer FDA-approved branded GLP-1s over compounded versions
- You have insurance that covers Wegovy or Ozempic
- You want behavioral coaching and nutrition support built into the program
- You’re already a WeightWatchers member or value the WW ecosystem
Edge case: If you have a complex medical history (diabetes, cardiovascular disease, thyroid conditions), Sequence’s higher provider involvement may be safer. Ro’s asynchronous model may not catch complications as quickly.
Are Ro or Sequence Good for Sensitive Metabolic Profiles?
Both programs require a provider evaluation before prescribing, which means neither will approve everyone. Sequence’s more intensive monitoring may be better suited to people with multiple health conditions.
Ro conducts basic metabolic labs and health screening as part of onboarding. Sequence includes more detailed metabolic panel reviews and more frequent check-ins, which gives providers more data points to catch issues early [1].
Who should be cautious with either program:
- People with a personal or family history of medullary thyroid carcinoma (GLP-1 medications carry an FDA black box warning for this)
- Those with pancreatitis history
- People with severe kidney or liver disease
- Pregnant or breastfeeding individuals
Neither Ro nor Sequence replaces a primary care physician for complex cases. If you have multiple conditions, talk to your doctor before enrolling in either platform.
For additional context on managing your overall health alongside a weight loss program, our guide on natural supplements for blood sugar control covers complementary approaches worth knowing about.
What Skin and Health Concerns Does Each Program Target?
Both Ro and Sequence target obesity and overweight conditions using GLP-1 receptor agonists, which work by slowing gastric emptying, reducing appetite, and improving blood sugar regulation. Neither is a skincare program.
Primary targets for both platforms:
- Weight loss in adults with a BMI of 27+ (with at least one weight-related condition) or BMI of 30+
- Blood sugar management (particularly relevant for people with type 2 diabetes or prediabetes)
- Reduction of cardiovascular risk factors associated with obesity
Where they differ in scope:
- Ro’s broader telehealth platform also covers sexual health, mental health, and primary care
- Sequence/WW adds behavioral health coaching, nutrition planning, and habit-change support
GLP-1 medications like semaglutide have also shown benefits in reducing inflammation and improving metabolic markers, which can have secondary effects on skin health and energy levels, though these are not the primary marketing claims of either platform.
Side Effects of Ro Compared to Side Effects of Sequence
The side effects are driven by the medication, not the platform. Both Ro and Sequence prescribe semaglutide (compounded or branded), so the side effect profile is essentially the same.
Common side effects of semaglutide (both programs):
- Nausea (most common, especially during dose escalation)
- Vomiting
- Diarrhea or constipation
- Fatigue
- Reduced appetite (this is also the mechanism of action)
Less common but serious:
- Pancreatitis
- Gallbladder problems
- Hypoglycemia (especially if combined with other diabetes medications)
- Injection site reactions
Where the platform matters for side effects: Sequence’s more frequent provider check-ins mean side effects are more likely to be caught and managed quickly. Ro’s asynchronous model means you’ll need to proactively message your provider if something feels wrong. Neither is inherently dangerous, but Sequence’s model offers faster feedback loops.
“The medication is the same molecule. What differs is how quickly your provider can respond if something goes wrong.” — A useful way to think about the clinical support gap between the two programs.
Can You Use Ro and Sequence Together?
No. Ro and Sequence are competing telehealth providers, and using both simultaneously would mean receiving duplicate GLP-1 prescriptions, which is medically unsafe and likely to be flagged by pharmacies. You should choose one program.
If you’re unsatisfied with one platform, you can cancel and transition to the other. Most providers will ask for a brief gap or require updated labs before starting a new prescription.
What you can combine with either program:
- Dietary changes and calorie tracking
- Resistance training (which helps preserve muscle mass during GLP-1-driven weight loss)
- Behavioral coaching (Sequence includes this; Ro does not)
- Supplements like probiotics for gut health, which may help manage GI side effects
Our review of the best gut health probiotic supplements is worth reading if you’re experiencing digestive side effects from GLP-1 therapy.
🔥 Ready to start your GLP-1 journey at the lowest possible cost? Try DirectMeds GLP1 Semaglutide — currently the most affordable compounded semaglutide program available in 2026.
How Long Do Results Take With Ro vs. Sequence?
Results timelines are similar for both programs because the medication drives the weight loss. Clinical studies on semaglutide show meaningful weight reduction typically begins within 4–12 weeks, with significant results (10–15% body weight loss) occurring over 16–68 weeks in clinical trial populations, according to published research on branded semaglutide.
Realistic expectations for both programs:
- Weeks 1–4: Dose escalation phase; appetite suppression begins, some nausea is common
- Weeks 4–12: Noticeable weight loss begins for most users
- Weeks 12–24: Significant progress for consistent users; plateau possible
- Weeks 24+: Continued loss or maintenance phase
Where the programs may differ in outcomes:
- Sequence’s behavioral coaching and nutrition integration may help users maintain better habits alongside medication, potentially improving long-term results
- Ro’s lower cost means more people can afford to stay on the program long enough to see results
The biggest predictor of results is consistency, not which platform you choose.
Common Mistakes People Make When Comparing Ro vs. Sequence
The most common mistake is choosing based on price alone without accounting for the total cost of care. Ro looks cheaper upfront, but if you need more provider support or end up switching programs, the cost difference narrows.
Other mistakes to avoid:
- Assuming compounded = inferior. Compounded semaglutide uses the same active ingredient as Wegovy. The difference is manufacturing source and FDA oversight, not efficacy per se.
- Ignoring insurance. If your insurance covers Wegovy, Sequence’s higher program cost may actually result in lower total out-of-pocket spending.
- Skipping the intake evaluation. Both programs require health screening. Rushing through it or underreporting conditions can lead to unsafe prescribing.
- Expecting medication to do all the work. GLP-1s suppress appetite; they don’t replace diet quality or exercise.
- Not comparing alternatives. Before committing to either platform, check DirectMeds GLP1 Semaglutide for potentially lower pricing on compounded semaglutide.
Alternative Options If Ro or Sequence Don’t Work for You
If neither Ro nor Sequence fits your needs, several alternatives exist in the GLP-1 telehealth space, including Hims & Hers, Noom Med, Found, and direct-pay compounded semaglutide programs.
Consider these alternatives if:
- Ro’s asynchronous model feels too hands-off
- Sequence’s pricing is outside your budget
- You want tirzepatide (Mounjaro/Zepbound) instead of semaglutide
- You prefer in-person care
DirectMeds GLP1 Semaglutide is worth serious consideration as an alternative. It’s positioned as one of the most affordable compounded semaglutide programs in 2026, making it accessible for people who want GLP-1 therapy without the premium price tag of either Ro or Sequence.
For those managing weight alongside other health factors, our article on meatless meal plans for nutritious eating and our fat loss vegetarian meal plan guide offer practical dietary strategies that complement any GLP-1 program.
FAQ
What is Ro Body and how does it work?
Ro Body is Ro Health’s telehealth weight loss program. You complete an online intake, a licensed provider reviews your health history and labs, and if approved, you receive compounded semaglutide shipped to your door. Provider communication happens via asynchronous messaging rather than live video calls. The program costs approximately $149–$199/month inclusive of medication and telehealth [1].
What is Sequence and who owns it now?
Sequence is a telehealth platform originally launched as Weekend Health. WeightWatchers acquired it for an effective net price of approximately $106 million to serve as the clinical backbone of its GLP-1 medication program [2]. It now operates under the WeightWatchers brand, offering prescription access to branded GLP-1 medications alongside WW’s behavioral coaching ecosystem [5].
Is compounded semaglutide from Ro as effective as branded Wegovy?
Compounded semaglutide contains the same active ingredient (semaglutide) as Wegovy. It is not FDA-approved as a finished drug product, but it is legally produced by licensed compounding pharmacies. Clinical effectiveness depends on dose, adherence, and lifestyle factors, not the brand name on the vial. Consult your provider for personalized guidance.
Which program is better for people without insurance?
Ro is generally better for uninsured patients because its compounded semaglutide program is priced at approximately $149–$199/month all-in. Sequence’s program costs more, and branded GLP-1 medications can exceed $1,000/month without insurance coverage [1]. DirectMeds GLP1 Semaglutide is another strong option for uninsured buyers looking for the lowest possible cost.
How do I know if I qualify for a GLP-1 prescription through Ro or Sequence?
Both platforms require a BMI of 27+ with at least one weight-related condition (such as hypertension, type 2 diabetes, or high cholesterol), or a BMI of 30+. You’ll also need to complete a health history intake and basic labs. Certain medical conditions may disqualify you, including a history of medullary thyroid carcinoma or pancreatitis.
Can I switch from Ro to Sequence or vice versa?
Yes, you can cancel one program and enroll in the other. Most platforms will require updated labs and a new provider evaluation before prescribing. Do not overlap prescriptions from two different providers, as this creates a safety risk and may be flagged by pharmacies.
Does Sequence require a WeightWatchers membership?
Sequence’s clinical program is now integrated with WeightWatchers, so access to its full ecosystem (behavioral coaching, nutrition tools, GLP-1 Success Program) typically requires a WW membership or subscription in addition to the medical program fee [5].
What is the fastest way to start a GLP-1 program in 2026?
Ro’s streamlined onboarding and asynchronous model typically allow faster prescription approval than Sequence’s video-visit-required process. For the most affordable and fast-access option, DirectMeds GLP1 Semaglutide is worth checking first.
Are there side effects specific to one program over the other?
No. Side effects are driven by semaglutide itself, not the platform. Common side effects include nausea, vomiting, diarrhea, and fatigue, especially during dose escalation. Sequence’s more frequent provider check-ins may help manage side effects more responsively than Ro’s asynchronous model.
What is the best alternative to Ro and Sequence for weight loss?
DirectMeds GLP1 Semaglutide is currently one of the most affordable compounded semaglutide programs in 2026. Other alternatives include Hims & Hers Weight, Noom Med, Found, and in-person obesity medicine clinics for those who prefer face-to-face care.
Conclusion
The Ro vs Sequence decision comes down to two things: how much clinical support you want, and how much you’re willing to pay for it. Ro wins on affordability and simplicity, making it a strong choice for self-directed patients who want GLP-1 access without a premium price tag. Sequence wins on clinical depth and behavioral integration, making it better for people who want regular physician contact and the full WeightWatchers support ecosystem.
Actionable next steps:
- Check your insurance first. If your plan covers Wegovy, Sequence’s higher program cost may be offset by medication savings.
- If you’re paying cash, compare Ro’s $149–$199/month rate against DirectMeds GLP1 Semaglutide, which may offer even lower pricing on compounded semaglutide.
- Assess your support needs. If you want a doctor you can video call regularly, Sequence is the better fit. If you’re comfortable with messaging, Ro works well.
- Don’t skip lifestyle changes. GLP-1 medications are tools, not shortcuts. Pair whichever program you choose with a solid nutrition plan, such as our fat loss vegetarian meal plan or meatless meal plan guide.
- Start today. The longer you delay, the longer results take. Get started with DirectMeds GLP1 Semaglutide if cost is your primary barrier.
References
[1] Ro Vs Sequence Weight Loss – https://trytrimi.com/blog/ro-vs-sequence-weight-loss
[2] Weightwatchers Moves Obesity Drug Market Sequence Purchase – https://www.mobihealthnews.com/news/weightwatchers-moves-obesity-drug-market-sequence-purchase
[3] Press – https://ro.co/press/
[5] Weight Loss Medication – https://www.weightwatchers.com/us/weight-loss-medication
Tags: Ro vs Sequence, GLP-1 weight loss, semaglutide, compounded semaglutide, Wegovy, telehealth weight loss, Ro Body program, Sequence WeightWatchers, weight loss medication, tirzepatide alternatives, GLP-1 cost comparison, online weight loss program
